{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:30:33Z","timestamp":1789500633845,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-025-06517-7","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T06:29:29Z","timestamp":1759904969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["To treat or not to treat young children with hepatitis C?\u2013\u2013real-life experience"],"prefix":"10.1007","volume":"184","author":[{"given":"Maria","family":"Pokorska-\u015apiewak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dobrzeniecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Talarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Aniszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Marczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"issue":"4","key":"6517_CR1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S2468-1253(19)30385-1","volume":"5","author":"J Schmelzer","year":"2020","unstructured":"Schmelzer J, Dugan E, Blach S, Coleman S, Cai Z, DePaola M et al (2020) Global prevalence of hepatitis C virus in children in 2018: a modelling study. Lancet Gastroenterol Hepatol 5(4):374\u2013392","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"6517_CR2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S2468-1253(19)30046-9","volume":"4","author":"G Indolfi","year":"2019","unstructured":"Indolfi G, Easterbrook P, Dusheiko G, El-Sayed MH, Jonas MM, Thorne C et al (2019) Hepatitis c virus infection in children and adolescents. Lancet Gastroenterol Hepatol 4(6):477\u2013487","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"6517_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jhep.2018.11.013","volume":"70","author":"L Modin","year":"2019","unstructured":"Modin L, Arshad A, Wilkes B, Benselin J, Lloyd C, Irving WL et al (2019) Epidemiology and natural history of hepatitis C virus infection among children and young people. J Hepatol 70(3):371\u2013378","journal-title":"J Hepatol"},{"issue":"2","key":"6517_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/INF.0000000000002913","volume":"40","author":"M Pokorska-\u015apiewak","year":"2021","unstructured":"Pokorska-\u015apiewak M, Dobrzeniecka A, Lipi\u0144ska M, Tomasik A, Aniszewska M, Marczy\u0144ska M (2021) Liver fibrosis evaluated with transient elastography in 35 children with chronic hepatitis C virus infection. Pediatr Infect Dis J 40(2):103\u2013108","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"6517_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100227","volume":"3","author":"F Malik","year":"2021","unstructured":"Malik F, Bailey H, Chan P, Collins IJ, Mozalevskis A, Thorne C et al (2021) Where are the children in national hepatitis C policies? A global review of national strategic plans and guidelines. JHEP Rep 3(2):100227","journal-title":"JHEP Rep"},{"issue":"2","key":"6517_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/hep.28995","volume":"66","author":"WF Balistreri","year":"2017","unstructured":"Balistreri WF, Murray KF, Rosenthal P, Bansal S, Lin CH, Kersey K et al (2017) The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12\u201317 years old with hepatitis C virus genotype 1 infection. Hepatology 66(2):371\u2013378","journal-title":"Hepatology"},{"issue":"6","key":"6517_CR7","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/jpn3.12045","volume":"78","author":"MM Jonas","year":"2024","unstructured":"Jonas MM, Romero R, Rosenthal P, Lin CH, Verucchi G, Wen J et al (2024) Sofosbuvir-velpatasvir in children 3\u201317 years old with hepatitis C virus infection. J Pediatr Gastroenterol Nutr 78(6):1342\u20131354","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"6517_CR8","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/hep.30123","volume":"68","author":"KF Murray","year":"2018","unstructured":"Murray KF, Balistreri WF, Bansal S, Whitworth S, Evans HM, Gonzalez-Peralta RP et al (2018) Safety and efficacy of ledipasvir-sofosbuvir with or without ribavirin for chronic hepatitis C in children ages 6\u201311. Hepatology 68(6):2158\u20132166","journal-title":"Hepatology"},{"issue":"1","key":"6517_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/hep.30821","volume":"71","author":"P Rosenthal","year":"2020","unstructured":"Rosenthal P, Schwarz KB, Gonzalez-Peralta RP, Lin CH, Kelly DA, Nightingale S et al (2020) Sofosbuvir and ribavirin therapy for children aged 3 to <12 years with hepatitis C virus genotype 2 or 3 infection. Hepatology 71(1):31\u201343","journal-title":"Hepatology"},{"issue":"2","key":"6517_CR10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/hep.30830","volume":"71","author":"KB Schwarz","year":"2020","unstructured":"Schwarz KB, Rosenthal P, Murray KF, Honegger JR, Hardikar W, Hague R et al (2020) Ledipasvir-sofosbuvir for 12 weeks in children 3 to <6 years old with chronic hepatitis c. Hepatology 71(2):422\u2013430","journal-title":"Hepatology"},{"issue":"2","key":"6517_CR11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/hep.30840","volume":"71","author":"MM Jonas","year":"2020","unstructured":"Jonas MM, Squires RH, Rhee SM, Lin CW, Bessho K, Feiterna-Sperling C et al (2020) Pharmacokinetics, safety, and efficacy of glecaprevir\/pibrentasvir in adolescents with chronic hepatitis C virus: part 1 of the DORA study. Hepatology 71(2):456\u2013462","journal-title":"Hepatology"},{"issue":"3","key":"6517_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000031","volume":"7","author":"RP Gonzalez-Peralta","year":"2023","unstructured":"Gonzalez-Peralta RP, Wirth S, Squires RH, Mutschler F, Lang T, Pawlowska M et al (2023) Elbasvir\/grazoprevir in children aged 3\u201318 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study. Hepatol Commun 7(3):e0031","journal-title":"Hepatol Commun"},{"issue":"1","key":"6517_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/hep.31841","volume":"74","author":"MM Jonas","year":"2021","unstructured":"Jonas MM, Rhee S, Kelly DA, Del Valle-Segarra A, Feiterna-Sperling C, Gilmour S et al (2021) Pharmacokinetics, safety, and efficacy of glecaprevir\/pibrentasvir in children with chronic HCV: part 2 of the DORA study. Hepatology 74(1):19\u201327","journal-title":"Hepatology"},{"issue":"2","key":"6517_CR14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/hep.32393","volume":"76","author":"G Indolfi","year":"2022","unstructured":"Indolfi G, Kelly D, Nebbia G, Iorio R, Mania A, Giacomet V et al (2022) Sofosbuvir-velpatasvir-voxilaprevir in adolescents 12 to 17 years old with HCV infection. Hepatology 76(2):445\u2013455","journal-title":"Hepatology"},{"key":"6517_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/jpn3.12160","author":"G Indolfi","year":"2024","unstructured":"Indolfi G, Gonzalez-Peralta RP, Jonas MM, Sayed MH, Fischler B, Sokal E (2024) ESPGHAN recommendations on treatment of chronic hepatitis C virus infection in adolescents and children including those living in resource-limited settings. J Pediatr Gastroenterol Nutr. https:\/\/doi.org\/10.1002\/jpn3.12160","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6517_CR16","unstructured":"Updated recommendations on treatment of adolescents and children with chronic HCV infection: policy brief. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"6517_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15827","author":"G Indolfi","year":"2024","unstructured":"Indolfi G, Easterbrook P, Giometto S, Malik F, Chou R, Lucenteforte E (2024) Efficacy and safety of DAA in children and adolescents with chronic HCV infection: a systematic review and meta-analysis. Liver Int. https:\/\/doi.org\/10.1111\/liv.15827","journal-title":"Liver Int"},{"key":"6517_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10184176","author":"M Pokorska-\u015apiewak","year":"2021","unstructured":"Pokorska-\u015apiewak M, Dobrzeniecka A, Aniszewska M, Marczy\u0144ska M (2021) Real-life experience with ledipasvir\/sofosbuvir for the treatment of chronic hepatitis C virus infection with genotypes 1 and 4 in children aged 12 to 17 years-results of the POLAC project. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10184176","journal-title":"J Clin Med"},{"issue":"4","key":"6517_CR19","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/idr14040061","volume":"14","author":"M Pokorska-\u015apiewak","year":"2022","unstructured":"Pokorska-\u015apiewak M, Dobrzeniecka A, Ogrodnik A (2022) Efficacy and safety of the treatment of chronic hepatitis C with sofosbuvir\/ledipasvir in children aged 5 to 10 years with comorbidities-a brief report. Infect Dis Rep 14(4):574\u2013578","journal-title":"Infect Dis Rep"},{"key":"6517_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15637","author":"M Pokorska-\u015apiewak","year":"2023","unstructured":"Pokorska-\u015apiewak M, Talarek E, Aniszewska M, Pluta M, Dobrzeniecka A, Marczy\u0144ska M et al (2023) Efficacy and safety of treatment with sofosbuvir\/velpatasvir in patients aged 6\u201318 years with chronic hepatitis C-results of the PANDAA-PED study. Liver Int. https:\/\/doi.org\/10.1111\/liv.15637","journal-title":"Liver Int"},{"issue":"3","key":"6517_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/MPG.0000000000001872","volume":"66","author":"G Indolfi","year":"2018","unstructured":"Indolfi G, Hierro L, Dezsofi A, Jahnel J, Debray D, Hadzic N et al (2018) Treatment of chronic hepatitis C virus infection in children: a position paper by the Hepatology Committee of European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 66(3):505\u2013515","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"6517_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.livres.2023.11.001","volume":"7","author":"M Li","year":"2023","unstructured":"Li M, Wulayin K, Lin S, Wu C, Chen L (2023) Should they wait? Two children under 3 years old infected by HCV 1b successfully treated by ledipasvir\/sofosbuvir: a report of two cases. Liver Res 7(4):361\u2013364","journal-title":"Liver Res"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06517-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06517-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06517-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T07:35:16Z","timestamp":1762846516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06517-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":22,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["6517"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06517-7","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"9 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The investigation was performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. Written informed consent was obtained from all the patients and\/or their parents\/guardians before their inclusion in the study. The local ethics committee of the Medical University of Warsaw approved both the PANDAA-PED Study and the POLAC Project (approval numbers KB\/87\/2019, 13 May 2019; KB\/136\/2020, September 14, 2020; No KB\/91\/A2020, 14 October 2020; and KB\/30\/A2021, April 19, 2021; No KB\/73\/A2022, November 7, 2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all participants involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"665"}}